A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Going out to breakfast with the family? Well, if you plan on going to Waffle House, you’re going to have to pay a little ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

Moderna’s efforts to develop a range of mRNA vaccines for influenza have been bolstered with funding of up to $750 million from investment firm Blackstone Life Sciences. The deal comes at a time ...

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all been flattened by an awful stomach bug at some point in our lives. For ...

Another late-2024 study found that viral shedding, the expulsion of viral particles, in the air related to transmissibility ...